| abstract |
The present invention relates to 2,7-disubstituted benzoxazole and 2,4-disubstituted oxazolo [5,4-c] pyridine compounds of the following formula (I) and salts thereof, a process for their preparation, treatment of the human or animal body For the treatment of these compounds, especially protein tyrosine kinase mediated diseases (eg tumor diseases) for use in the treatment (including prevention) of the body of an animal, especially the human (especially with respect to proliferative diseases) Of the present invention alone or in combination with one or more pharmaceutically active compounds, for the manufacture of a pharmaceutical preparation for the treatment of the disease, a method for the treatment of the disease, and a medicament for the treatment of the disease Relates to the formulation. The compound has the formula (I) [Chemical 1] [Wherein the symbols are as defined herein] belongs to. The compound inhibits, for example, JAK2 and JAK3. |